Landmark Study Confirms Tylenol Safety During Pregnancy, Refutes Autism Claims
In a significant development for maternal health, a comprehensive new study from Denmark has definitively shown that taking acetaminophen, commonly known as Tylenol in the United States, during pregnancy does not increase the risk of autism in children. Published in Jama Pediatrics, this research challenges previous unfounded assertions, including those made by the Trump administration, which had targeted Tylenol use as a major cause of autism.
Robust Data from Denmark's Healthcare System
Leveraging Denmark's extensive national healthcare registry, researchers tracked over 1.5 million children born between 1997 and 2022. Among this vast cohort, 31,098 children were exposed to Tylenol in utero. The findings revealed that autism was diagnosed in only 1.8% of children exposed to Tylenol, compared to 3% of those who were not exposed. This data underscores the medication's safety profile and aligns with earlier studies suggesting autism is strongly genetic, rather than linked to pain reliever use.
Political Influence and Public Health Impact
Former President Donald Trump had repeatedly cautioned against Tylenol use during pregnancy, claiming it was associated with "a very increased risk of autism." Despite these warnings, health experts emphasize that Tylenol remains one of the few safe options for pain control and fever reduction in pregnancy. Non-steroidal anti-inflammatory drugs like ibuprofen are typically not recommended due to risks such as bleeding and placenta issues.
The political discourse appears to have influenced public behavior. Following a September 2025 announcement by the U.S. Food and Drug Administration (FDA) about a potential label change for acetaminophen, a Lancet study noted a 16% drop in Tylenol orders for pregnant women in emergency rooms initially. Jeremy Faust, a co-author of that study and an emergency physician at Mass General Brigham, stated, "Words are affecting behavior," highlighting how health messaging can sway medical decisions.
Broader Context and Future Implications
Other studies, including a 2024 Swedish analysis, found only marginal links that disappeared when accounting for siblings, reinforcing the genetic basis of autism. A 2025 U.S. review suggested a potential relationship but noted confounders, such as higher pain levels in autistic pregnant individuals possibly leading to more Tylenol use. Health officials continue to advocate for evidence-based guidelines, stressing that Tylenol plays a crucial role in managing pain and fevers, which are themselves significant health concerns during pregnancy.
As the debate evolves, this new Danish study provides robust reassurance to healthcare providers and expectant parents, affirming that Tylenol remains a safe and effective option. The findings call for clearer communication in public health to prevent misinformation from undermining essential medical care.
